| Dr James Michael Dobbin, MD | |
|
850 Aquidneck Ave, Unit B-9, Middletown, RI 02842-7244 | |
| (401) 849-4448 | |
| (401) 849-6479 |
| Full Name | Dr James Michael Dobbin |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 850 Aquidneck Ave, Middletown, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164426011 | NPI | - | NPPES |
| 007053 | Other | RI | TUFTS ID NUMBER |
| 1009006 | Other | RI | UNITED HEALTH |
| 0000002519 | Other | RI | RI BLUE CROSS |
| 0400001942 | Other | RI | RAILROAD MEDICARE |
| 1041 | Other | RI | NEIGHBORHOOD HEALTH PLAN |
| 200164 | Other | RI | BLUE CHIP ID NUMBER |
| 7002779 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD07053 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Michael Dobbin, MD 850 Aquidneck Ave, Unit B-9, Middletown, RI 02842-7244 Ph: (401) 849-4448 | Dr James Michael Dobbin, MD 850 Aquidneck Ave, Unit B-9, Middletown, RI 02842-7244 Ph: (401) 849-4448 |
News Archive
University of Minnesota researchers have found a group of cells in the intestinal system of mice that are proven to turn on T-cells, cells that help fight infection.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
Technology that could enhance plants' seed oil content for food and animal feed applications has been licensed to BASF Plant Science under an exclusive commercial agreement with Michigan State University.
A team led by scientists from The Scripps Research Institute has discovered a genetic cause of progressive hearing loss. The findings will help scientists better understand the nature of age-related decline in hearing and may lead to new therapies to prevent or treat the condition.
› Verified 6 days ago
Dr. Steven Franklin Freedman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Aquidneck Ave, Unit B9, Middletown, RI 02842 Phone: 401-849-4448 Fax: 401-849-6479 |